MEP39908A - Novel anticholinergic agents that can be used as medicaments and method for the production thereof - Google Patents

Novel anticholinergic agents that can be used as medicaments and method for the production thereof

Info

Publication number
MEP39908A
MEP39908A MEP-399/08A MEP39908A MEP39908A ME P39908 A MEP39908 A ME P39908A ME P39908 A MEP39908 A ME P39908A ME P39908 A MEP39908 A ME P39908A
Authority
ME
Montenegro
Prior art keywords
medicaments
production
anticholinergic agents
novel anticholinergic
novel
Prior art date
Application number
MEP-399/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Helmut Meissner
Gerd Morschhaeuser
Michael Paul Pieper
Gerald Pohl
Richard Reichl
Georg Speck
Rolf Banholzer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MEP39908A publication Critical patent/MEP39908A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
MEP-399/08A 2000-10-14 2001-09-28 Novel anticholinergic agents that can be used as medicaments and method for the production thereof MEP39908A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10050994A DE10050994A1 (de) 2000-10-14 2000-10-14 Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
PCT/EP2001/011226 WO2002032899A1 (de) 2000-10-14 2001-09-28 Neue als arzneimittel einsetzbare anticholinergika sowie verfahren zu deren herstellung
YUP-295/03A RS50464B (sr) 2000-10-14 2001-09-28 Novi antiholinergici koji se mogu primeniti kao lekovi, kao i postupak za njihovo dobijanje

Publications (1)

Publication Number Publication Date
MEP39908A true MEP39908A (en) 2011-02-10

Family

ID=7659808

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-399/08A MEP39908A (en) 2000-10-14 2001-09-28 Novel anticholinergic agents that can be used as medicaments and method for the production thereof

Country Status (38)

Country Link
EP (2) EP1382606A3 (ko)
JP (2) JP4109106B2 (ko)
KR (1) KR100830359B1 (ko)
CN (1) CN1275962C (ko)
AR (1) AR035589A1 (ko)
AT (1) ATE259805T1 (ko)
AU (2) AU2002213975B2 (ko)
BG (1) BG66225B1 (ko)
BR (1) BR0114635A (ko)
CA (1) CA2425557C (ko)
DE (2) DE10050994A1 (ko)
DK (1) DK1325001T3 (ko)
EA (1) EA005816B1 (ko)
EC (1) ECSP034542A (ko)
EE (1) EE05179B1 (ko)
ES (1) ES2215147T3 (ko)
HK (1) HK1060566A1 (ko)
HR (1) HRP20030278B1 (ko)
HU (1) HUP0301203A3 (ko)
IL (2) IL155334A0 (ko)
ME (1) MEP39908A (ko)
MX (1) MXPA03003160A (ko)
MY (1) MY127144A (ko)
NO (1) NO328207B1 (ko)
NZ (1) NZ525836A (ko)
PE (1) PE20020433A1 (ko)
PL (1) PL207311B1 (ko)
PT (1) PT1325001E (ko)
RS (1) RS50464B (ko)
SA (1) SA01220414B1 (ko)
SI (1) SI1325001T1 (ko)
SK (1) SK287138B6 (ko)
TR (1) TR200400376T4 (ko)
TW (1) TWI306098B (ko)
UA (1) UA73804C2 (ko)
UY (1) UY26958A1 (ko)
WO (1) WO2002032899A1 (ko)
ZA (1) ZA200302914B (ko)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US7405224B2 (en) 2002-01-31 2008-07-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
DE10203753A1 (de) * 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10256317A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Arzneimittel enthaltend Betamimetika und ein neues Anticholinergikum
DE10216429A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
US7084153B2 (en) 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US7417051B2 (en) 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
ATE302774T1 (de) * 2002-04-12 2005-09-15 Boehringer Ingelheim Pharma Arzneimittel enthaltend betamimetika und ein neues anticholinergikum
DE10224091A1 (de) * 2002-05-31 2003-12-11 Boehringer Ingelheim Pharma Technisches Verfahren zur Herstellung von Tropenol
DE10230751A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
DE10230750A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
ATE349210T1 (de) * 2002-07-09 2007-01-15 Boehringer Ingelheim Pharma Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
PL375511A1 (en) * 2002-08-14 2005-11-28 Boehringer Ingelheim Pharma Gmbh & Co.Kg Aerosol formulation for inhalation containing an anticholinergic agent
DE10237739A1 (de) * 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
DE10323966A1 (de) * 2003-05-27 2004-12-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
US7332175B2 (en) 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
US7462367B2 (en) 2003-07-11 2008-12-09 Boehringer Ingelheim International Gmbh Anticholinergic powder formulations for inhalation
DE10331350A1 (de) * 2003-07-11 2005-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation enthaltend ein neues Anticholinergikum
CA2533792C (en) * 2003-07-28 2012-09-11 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising steroids and fluorene carboxylic acid esters
CA2533786A1 (en) * 2003-07-28 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders
WO2005013992A1 (en) * 2003-07-28 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising betamimetics and an anticholinergic agent
EP1651224B1 (en) * 2003-07-31 2011-10-05 Boehringer Ingelheim International GmbH Medicaments for inhalation comprising an anticholinergic and a betamimetic
EP1504756A1 (en) * 2003-08-06 2005-02-09 Kyowa Hakko Kogyo Co., Ltd Medicament compositions comprising a heterocyclic compound and an anticholinergic
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
EP1706118A1 (en) * 2004-01-09 2006-10-04 Boehringer Ingelheim International GmbH New pharmaceutical compositions based on a scopineester and nicotinamide derivatives
US7507745B2 (en) 2004-02-20 2009-03-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
EP1718301A1 (en) * 2004-02-20 2006-11-08 Boehringer Ingelheim International GmbH Pharmaceutical compositions based on anticholinergics and pegsunercept
US20050186175A1 (en) * 2004-02-20 2005-08-25 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins
DE102004016179A1 (de) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von proliferativen Prozessen
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
ES2322148T3 (es) * 2004-08-11 2009-06-17 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
DE102004056578A1 (de) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Formoterol und ein Steroid
WO2006087316A1 (en) * 2005-02-16 2006-08-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising anticholinergics and etiprednol
JP2008532973A (ja) * 2005-03-09 2008-08-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬とpde5−阻害剤に基づく新規な医薬組成物
CA2609429A1 (en) * 2005-05-31 2006-12-07 Boehringer Ingelheim International Gmbh Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
EP1898894A1 (en) * 2005-06-17 2008-03-19 Boehringer Ingelheim International GmbH Mrp iv inhibitors for the treatment of respiratory diseases
DE102005030733A1 (de) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
CN101208316B (zh) 2005-08-15 2012-05-09 贝林格尔·英格海姆国际有限公司 制备β-模拟物的方法
CA2626612A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
DE102005055961A1 (de) * 2005-11-24 2007-05-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055963A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055957A1 (de) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
EP2051714B1 (de) 2006-08-07 2011-04-13 Boehringer Ingelheim International GmbH Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
US20080207659A1 (en) 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
CN103497185A (zh) 2007-03-14 2014-01-08 兰贝克赛实验室有限公司 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物
ES2569359T3 (es) 2007-07-06 2016-05-10 Vectura Delivery Devices Limited Inhalador
JP2010533676A (ja) * 2007-07-18 2010-10-28 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患の治療のための新規な組成物
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2082771A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082772A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082767A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082768A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082766A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Blister Strip Coil Forming
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
JP5670421B2 (ja) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング コンポーネント表面のコーティング方法
WO2010133294A2 (de) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapter, inhalationseinrichtung und zerstäuber
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
UA107097C2 (en) 2009-11-25 2014-11-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Dispenser
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
WO2014096115A1 (en) 2012-12-21 2014-06-26 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
CA2888431C (en) 2012-12-21 2021-10-19 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical formulation comprising ciclesonide
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10195374B2 (en) 2014-05-07 2019-02-05 Boehringer Ingelheim International Gmbh Container, nebulizer and use
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
LT3928818T (lt) 2014-05-07 2023-03-27 Boehringer Ingelheim International Gmbh Purkštuvas ir talpa
MX370430B (es) 2014-06-18 2019-12-13 Boehringer Ingelheim Vetmedica Gmbh Antagonistas muscarínicos y sus combinaciones para el tratamiento de enfermedades de las vías respiratorias en caballos.
MA45011A (fr) * 2015-09-04 2021-06-02 Janssen Pharmaceutica Nv Composé thérapeutique contre la douleur et sa synthèse
CN113292574B (zh) * 2020-02-21 2022-05-03 四川大学 一类手性多环的托品烷化合物及其制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
HK1060566A1 (en) 2004-08-13
TR200400376T4 (tr) 2004-03-22
CA2425557C (en) 2007-11-13
UY26958A1 (es) 2002-06-20
PE20020433A1 (es) 2002-06-28
DE50101524D1 (de) 2004-03-25
RS50464B (sr) 2010-03-02
MY127144A (en) 2006-11-30
EP1325001A1 (de) 2003-07-09
HUP0301203A2 (hu) 2003-10-28
AR035589A1 (es) 2004-06-16
AU2002213975B2 (en) 2006-11-09
JP2008120834A (ja) 2008-05-29
HRP20030278B1 (en) 2006-02-28
PT1325001E (pt) 2004-07-30
CN1275962C (zh) 2006-09-20
ECSP034542A (es) 2003-06-25
TWI306098B (en) 2009-02-11
BG107688A (bg) 2003-09-30
MXPA03003160A (es) 2005-09-09
JP2004511557A (ja) 2004-04-15
ATE259805T1 (de) 2004-03-15
EE05179B1 (et) 2009-06-15
BG66225B1 (bg) 2012-06-29
CN1468236A (zh) 2004-01-14
PL207311B1 (pl) 2010-11-30
DE10050994A1 (de) 2002-04-18
CA2425557A1 (en) 2003-04-11
KR20030041165A (ko) 2003-05-23
SK4352003A3 (en) 2003-08-05
UA73804C2 (en) 2005-09-15
IL155334A (en) 2009-02-11
WO2002032899A1 (de) 2002-04-25
IL155334A0 (en) 2003-11-23
EA005816B1 (ru) 2005-06-30
EA200300459A1 (ru) 2003-10-30
JP4109106B2 (ja) 2008-07-02
NO20031693L (no) 2003-05-28
SA01220414B1 (ar) 2007-01-20
NO328207B1 (no) 2010-01-11
AU1397502A (en) 2002-04-29
EP1382606A3 (de) 2004-10-13
PL360673A1 (en) 2004-09-20
SK287138B6 (sk) 2010-01-07
ES2215147T3 (es) 2004-10-01
DK1325001T3 (da) 2004-06-21
ZA200302914B (en) 2003-11-14
NO20031693D0 (no) 2003-04-11
EP1382606A2 (de) 2004-01-21
NZ525836A (en) 2004-09-24
BR0114635A (pt) 2004-02-10
HRP20030278A2 (en) 2005-02-28
EE200300151A (et) 2003-06-16
HUP0301203A3 (en) 2006-05-29
KR100830359B1 (ko) 2008-05-20
YU29503A (sh) 2006-03-03
SI1325001T1 (en) 2004-08-31
EP1325001B1 (de) 2004-02-18

Similar Documents

Publication Publication Date Title
MEP39908A (en) Novel anticholinergic agents that can be used as medicaments and method for the production thereof
MEP58808A (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
MEP45308A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
YU4397A (sh) Novi supstituisani oksazolidinoni
HRP20041042A2 (en) Novel substituted sulfamate anticonvulsant derivatives
ME00060B (me) Nova heterociklična jedinjenja, njihovo dobijanje i njihova upotreba kao medikamenata, a naročito kao anti-bakterijskih agenasa
ME00595B (me) 2-okso-1-pirolidinski derivati, postupci za njihovo dobijanje i njihove primene
ME00159B (me) DERIVATI HINOLINA l IZOHINOLINA, POSTUPAK ZA NJIHOVO DOBIJANJE l NJIHOVA PRIMENA KAO SUPRESORA ZAPALJENJA
HRP20050432A2 (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases
YU45403A (sh) Novi 1,2-difenil-azetidinoni, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena za lečenje poremećaja u metabolizmu lipida
MEP43408A (en) Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
ECSP045159A (es) &#34;antagonistas nk1&#34;
BRPI0409716A (pt) derivados de 2-acilamino-4-feniltiazol, seu preparo e sua aplicação em terapêutica
SE0104140D0 (sv) Novel Compounds
SE0102438D0 (sv) New compounds
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
MEP9309A (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same
DK1613304T3 (da) DPP-IV-inhibitorer
EA200500342A1 (ru) Гетероциклические замещённые пиперазины для лечения шизофрении
GEP20022676B (en) 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
MXPA02011370A (es) Iminoazinas substituidas.
WO2002032898A3 (de) Neue anticholinergika, verfahren zu deren herstellung und deren verwendung als arzneimittel
GB0313612D0 (en) Organic compounds
BRPI0519267A2 (pt) derivado de quinolina, seu uso, produÇço e medicamento contendo o mesmo